Lingamneni Anila (CIK 0001808414)

Latest company ownership

HAE - HAEMONETICS CORP
Role: EVP, Chief Technology Officer
Shares held
21,331
Last filed at
Jul 15, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jul 11, 2024 Jul 15, 2024 HAEMONETICS CORP EVP, Chief Technology Officer Sell 28.8 -2,215 -9.41% ✓ $199.4K
May 28, 2024 May 29, 2024 HAEMONETICS CORP EVP, Chief Technology Officer Sell 97.5 +8,861 60.34% ✗ $505.4K
May 17, 2024 May 21, 2024 HAEMONETICS CORP EVP, Chief Technology Officer Sell 91.3 +3,045 26.16% ✗ $33.4K
May 15, 2024 May 17, 2024 HAEMONETICS CORP EVP, Chief Technology Officer Sell 22.5 -655 -5.33% ✗ $62.7K
May 6, 2024 May 8, 2024 HAEMONETICS CORP EVP, Chief Technology Officer Sell 20.0 -2,305 -15.79% ✓ $219K
Apr 15, 2024 Apr 17, 2024 HAEMONETICS CORP EVP, Chief Technology Officer Sell 26.3 -184 -1.27% ✗ $15.6K
Sep 11, 2023 Sep 13, 2023 HAEMONETICS CORP EVP, Chief Technology Officer Sell 25.0 -2,305 -13.72% ✓ $207.5K
May 30, 2023 Jun 1, 2023 HAEMONETICS CORP EVP, Chief Technology Officer Sell 22.5 -2,304 -12.06% ✗ $192K
May 18, 2023 May 19, 2023 HAEMONETICS CORP EVP, Chief Technology Officer Sell 22.5 -1,385 -6.76% ✗ $115.4K
May 15, 2023 May 17, 2023 HAEMONETICS CORP EVP, Chief Technology Officer Sell 91.3 +3,046 17.46% ✗ $28.4K
Apr 14, 2023 Apr 18, 2023 HAEMONETICS CORP EVP, Chief Technology Officer Sell 26.3 -176 -1.02% ✗ $14.9K
May 19, 2022 May 23, 2022 HAEMONETICS CORP EVP, Chief Technology Officer Sell 42.5 -1,384 -7.40% ✗ $81.8K
Apr 18, 2022 Apr 19, 2022 HAEMONETICS CORP EVP, Chief Technology Officer Sell 46.3 -189 -1.33% ✗ $10.7K
May 18, 2021 May 20, 2021 HAEMONETICS CORP EVP, Chief Technology Officer Sell 90.0 +10,513 284.98% ✗ $5.1K
Apr 16, 2021 Apr 20, 2021 HAEMONETICS CORP EVP, Chief Technology Officer Sell 46.3 -170 -4.70% ✗ $20.3K